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The IFN-1, IFN-2, and IFN-3 cytokine 
family, also called IL-29, IL-28A, and IL-28B, re-
spectively, has recently been identified (Kotenko 
et al., 2003; Sheppard et al., 2003) and shown to 
be related to type I IFNs (IFN-Is) and the IL-10 
family of cytokines. IFN-s signal via a het-
erodimeric receptor, consisting of one chain 
unique for IFN- (IFN-R1 or IL-28R) and 
another  chain  (IL-10R2),  which  is  shared 
with IL-10–related cytokines. Similar to IFN-Is,   
IFN-s possess antiviral, antitumor, and vari-
ous  immune-modulating functions (Li et al., 
2009). In contrast to the ubiquitous expression 
of the IFN-I receptor (IFN-IR), the expression 
of the IFN- receptor is restricted to certain 
cell types, including epithelial cells and plasmacy-
toid DCs (pDCs; Ank et al., 2008; Sommereyns 
et al., 2008). Exposure to viruses or analogues 
of nucleic acids such as CpG-oligonucleotide 
(ODN), conditions known to trigger the produc-
tion of IFN-Is, also induces IFN-s and largely   
depends on similar signaling components (Coccia 
et al., 2004; Onoguchi et al., 2007; Osterlund 
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Polyinosinic:polycytidylic acid (poly IC), a double-stranded RNA, is an effective adjuvant  
in vivo. IFN-s (also termed IL-28/29) are potent immunomodulatory and antiviral cytokines. 
We demonstrate that poly IC injection in vivo induces large amounts of IFN-, which 
depended on hematopoietic cells and the presence of TLR3 (Toll-like receptor 3), IRF3 (IFN 
regulatory factor 3), IRF7, IFN-I receptor, Fms-related tyrosine kinase 3 ligand (FL), and 
IRF8 but not on MyD88 (myeloid differentiation factor 88), Rig-like helicases, or lympho-
cytes. Upon poly IC injection in vivo, the IFN- production by splenocytes segregated with 
cells phenotypically resembling CD8+ conventional dendritic cells (DCs [cDCs]). In vitro 
experiments revealed that CD8+ cDCs were the major producers of IFN- in response to 
poly IC, whereas both CD8+ cDCs and plasmacytoid DCs produced large amounts of IFN- 
in response to HSV-1 or parapoxvirus. The nature of the stimulus and the cytokine milieu 
determined whether CD8+ cDCs produced IFN- or IL-12p70. Human DCs expressing 
BDCA3 (CD141), which is considered to be the human counterpart of murine CD8+ DCs, 
also produced large amounts of IFN- upon poly IC stimulation. Thus, IFN- production in 
response to poly IC is a novel function of mouse CD8+ cDCs and their human equivalents.
© 2010 Lauterbach et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six   
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spleen cDCs bearing the CD8 molecule because a rare sub-
set of CD8 cDCs with the cross-presenting ability of CD8+ 
cDCs has been identified in spleen. They lack CD11b and 
CD172a expression and express CD205 and high levels of 
CD24 (Bedoui et al., 2009). Upon treatment with Fms- 
related tyrosine kinase 3 ligand (FL), the numbers of those 
equivalent of CD8+ (eCD8) cDCs can be greatly enhanced 
in vivo (Bedoui et al., 2009). Likewise, FL treatment of BM 
cells can drive eCD8 cDCs (as well as eCD8 cDCs and 
pDCs) in vitro. Recent work on mice deficient for, or carry-
ing mutations in, transcription factors such as IRF8 or Batf3 
demonstrated the absence of CD8+ cDCs in lymphoid or-
gans and lack of eCD8 cDCs in peripheral organs as well as 
the failure to drive eCD8 cDCs in FL cultures (Schiavoni   
et al., 2002; Aliberti et al., 2003; Hildner et al., 2008; Edelson 
et al., 2010). Recently, cross-presenting CD8 cDCs in other   
organs such as lymph nodes have also been characterized (Henri 
et al., 2010).
CD8 is not expressed on human DCs, whereas CD4 is 
expressed on all DC subsets. A set of antibodies designated 
BDCA1–4 has been developed to differentiate between pDCs 
and  subsets  of  cDCs  (Dzionek  et  al.,  2000). The  human 
BDCA3-positive cDCs have been proposed as the human 
eCD8 cDCs. Common to the mouse CD8+ DCs, BDCA3-
positive cDCs selectively express high levels of Clec9a and 
Necl2 but low amounts of CD11b (Shortman et al., 2009). 
Genome-wide transcriptional analysis substantiated a close 
relationship of murine CD8+ cDCs with human BDCA3+ 
cDCs (Robbins et al., 2008). Like mouse CD8+ and eCD8 
cDCs, human BDCA3+ cDCs have been found in various 
organs, including blood, spleen, tonsils, lymph nodes, and liver 
(Dzionek et al., 2000; Lindstedt et al., 2005;  Velásquez-Lopera   
et al., 2008; Bamboat et al., 2009; Poulin et al., 2010). Recently, 
the functional hallmarks of murine CD8+ cDCs, IL-12p70 
production,  cross-presentation  ability,  and TLR3  expression, 
have also been shown to align with human BDCA3+ cDCs. 
This strongly suggests that BDCA3+ cDCs are the human 
equivalents of murine CD8+ cDCs (Bachem et al., 2010; 
Crozat et al., 2010; Jongbloed et al., 2010; Poulin et al., 2010; 
Villadangos and Shortman, 2010).
Expression of the different nucleic acid–sensing systems 
TLR3, TLR7, or TLR9 and the RLHs varies among DC sub-
sets (Hochrein and O’Keeffe, 2008). The downstream func-
tions after engagement of these receptors also differ among 
the different DCs. pDCs predominantly use TLR7 and TLR9 
for nucleic acid sensing, resulting in the high production of 
IFN-I and IFN-s. Among cDCs, CD8+ cDCs highly express 
TLR3 but lack expression of TLR7 (Edwards et al., 2003) 
and, in stark contrast to CD8 cDCs, hardly express the RLHs 
and as a consequence are unable to detect the single-stranded 
RNA viruses Sendai or influenza virus (Luber et al., 2010).
DNA viruses such as poxviruses or herpesviruses are recog-
nized by pDCs predominantly via a TLR9- and MyD88 (mye-
loid differentiation factor 88)-dependent pathway, whereas other 
cells including cDCs use MyD88-independent, poorly defined 
recognition pathways (Lund et al., 2003; Hochrein et al., 2004; 
et al., 2007; Ank et al., 2008). The precise role of IFN-s in 
viral infections is not yet known. However, it plays a role in 
Toll-like receptor (TLR)–induced protection against mucosal 
viral infections, and recent studies link the IL28B gene with 
an ability to clear and recover from Hepatitis C infection 
(Ank et al., 2008; Ge et al., 2009; Suppiah et al., 2009; Tanaka 
et al., 2009; Thomas et al., 2009). Thus, it is of utmost impor-
tance to understand the cellular origin of IFN-s and the 
regulation of its production.
Several cell types, including PBMCs, monocyte-derived 
DCs, and pDCs, stimulated with various agents in vitro have 
been described to produce IFN-, mostly analyzed by gene 
transcripts (Kotenko et al., 2003; Sheppard et al., 2003; Coccia   
et al., 2004; Osterlund et al., 2005; Ank et al., 2008). Polyinosinic:
polycytidylic acid (poly IC) is used as an important immune 
stimulant and is an excellent adjuvant for the induction of 
TH1 CD4 T cell responses in a DC-targeted vaccine model 
(Schulz et al., 2005; Longhi et al., 2009). It is a mimic of viral 
double-stranded RNA (dsRNA) and is recognized by TRIF-
dependent TLR3 or Cardif (also known as IPS-1, MAVS, and 
VISA)-dependent  Rig-like  helicases  (RLHs).  Injection  of 
poly IC in vivo induces large systemic levels of IFN- (Field 
et al., 1967). Nonhematopoietic cells using the RLH MDA5 
have been identified to be responsible for the majority of this 
systemic IFN- (Gitlin et al., 2006; Longhi et al., 2009).
IFN-I production in response to RLH or TLR signaling 
depends on the presence and the activation of transcription 
factors of the IFN regulatory factor (IRF) family. IRF3 and 
IRF7 have been described to be important for the optimal 
production of IFN-I (Tamura et al., 2008). However, depend-
ing on the cellular source and the pattern recognition recep-
tor (PRR) used, the role of individual IRFs varies (Tamura et al., 
2008). For the production of IFN-s, much less is known, but 
a role for IRF3 and IRF7 has been suggested for different 
stimuli and different cells, including DCs (Coccia et al., 2004; 
Onoguchi et al., 2007; Osterlund et al., 2007).
Based on phenotypic, functional, and developmental dif-
ferences, the DCs of the spleen are divided into several subsets. 
A major distinction can be made between pDCs and conven-
tional DCs (cDCs). pDCs are best known for their outstand-
ing capacity for IFN- production. cDCs are further grouped 
into CD8+ and CD8 cDC subsets (Vremec et al., 1992). 
The CD8 cDCs can be further segregated by the expression 
of CD4 into CD4+ cDCs and double negative (DN) cDCs 
(Vremec et al., 2000), but other surface markers including 
CD11b and CD172a are similarly highly expressed by CD4+ 
and  DN  cDCs.  Quantitative  proteomic  analysis  of  spleen 
cDC subsets clearly demonstrated the relatedness of the two 
CD8 cDC subsets distinguishing these DCs from CD8+ 
cDCs (Luber et al., 2010).
CD8+  cDCs  are  well  known  for  the  production  of   
IL-12p70 in various organs, including spleen, lymph nodes, 
thymus, and liver (Reis e Sousa et al., 1997; Hochrein et al., 
2001; Pillarisetty et al., 2004). Another important function of 
CD8+ cDCs is their outstanding capacity for cross-presentation 
(Shortman et al., 2009). Cross-presentation is not confined to JEM VOL. 207, November 22, 2010 
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Mice that lacked IRF3 had a completely abrogated IFN- 
production and an 80% reduction in the production of   
IFN-. Mice lacking IRF7 showed the inverse pattern with a 
complete lack of IFN- production and an 80% reduction in 
the IFN- production. Mice deficient for both transcription 
factors (IRF3+7) produced neither IFN- nor IFN-. Thus, 
the full production of poly IC–induced IFN- and IFN-  
in vivo depended on the presence of IRF3 and IRF7 (Fig. 2).
IFN- production to poly IC in vivo depends on 
hematopoietic cells, FL, and IRF8 but not on lymphocytes
Systemic IFN- in response to poly IC originates from non-
hematopoietic cells via MDA5 recognition (Gitlin et al., 2006; 
Longhi et al., 2009). To test for the origin of systemic IFN-, 
we made BM chimeras of WT and TLR3 or TRIF mice. The 
data show that TLR3-KO and TRIF-KO mice, which re-
ceived a WT BM, gained systemic IFN-–producing capacity 
upon poly IC injection (Fig. 3 A). In contrast, WT mice re-
constituted with TLR3-KO or TRIF-KO BM were unable   
to produce systemic IFN- to poly IC (Fig. 3 A). Thus, hemato-
poietic cells are the origin of this IFN-.
Krug et al., 2004; Samuelsson et al., 2008; Siegemund et al.,   
2009; Wilkins and Gale, 2010).
In this study, we found that poly IC induced systemic 
production of IFN-, and we investigated the molecular 
and cellular events required for this production. Mice that 
lacked CD8+ cDCs were unable to produce IFN- to poly IC 
in vivo. This production depended on TLR3, IRF3, IRF7, and 
IFN-IR. We identified mouse CD8+ and eCD8 cDCs as 
the major producers of IFN- in response to poly IC in vitro. 
Similar to mice, among human cDCs, human eCD8 cDCs 
isolated via expression of BDCA3 were found to produce 
large quantities of IFN-s upon stimulation with poly IC. 
Thus, IFN- production to poly IC was identified as a hallmark 
function of eCD8 cDCs in mice and man.
RESULTS
Poly IC induces systemic IFN- production in vivo,  
which depends on TLR3 and IFN-IR
Poly IC is sensed by redundant pathways, and roles for RLHs 
as well as TLR3 have been described previously (Alexopoulou 
et al., 2001; Gitlin et al., 2006). Injection of poly IC is known 
to induce large systemic levels of IFN-. In this study, we 
found that the injection of poly IC in WT mice also induced 
large quantities of IFN- (Fig. 1). To determine the PRRs 
involved in this IFN- production, we injected poly IC into 
mice deficient for various PRRs or their adaptor molecules, 
specifically TLR3, MyD88, or Cardif (also known as MAVS, 
IPS-1, or  VISA), and measured IFN- as well as IFN- in the 
corresponding sera (Fig.  1). Large amounts of IFN- and 
IFN- were induced in WT and MyD88-KO mice (Fig. 1), 
demonstrating that MyD88-dependent TLRs were not in-
volved. This also suggests that pDCs, which largely depend on 
MyD88 for IFN production, unlikely contributed to the pro-
duction of both cytokines under those conditions. However, 
deficiency of TLR3 resulted in abrogated IFN- production 
with no effect on the production of IFN- (Fig. 1). In contrast, 
Cardif deficiency revealed no effects on IFN- production 
but, consistent with previous studies, using MDA5-deficient 
mice, complete abrogation of serum IFN- (Fig. 1; Gitlin et al., 
2006; Longhi et al., 2009). Thus, whereas poly IC induced 
large systemic levels of both IFN- and IFN- in WT mice, 
the dependence on TLR3 or Cardif for their production seems 
to be mutually exclusive.
It has been described that optimal IFN- production to 
poly IC in vivo requires expression of a functional IFN-IR 
(Barchet et al., 2002). A role for IFN-IR has also been proposed 
for the production of IFN- in response to viruses (Ank et al., 
2008). In this study, we found that systemic production of 
IFN- and IFN- in response to poly IC was largely depen-
dent on the presence of the IFN-IR (Fig. 1).
IFN- production to poly IC in vivo depends  
on IRF3 and IRF7
To get an insight into the transcription factors involved in the 
IFN- production to poly IC in vivo, we challenged mice 
deficient for either IRF3 or IRF7 or both IRF3+7 (Fig. 2). 
Figure 1.  Poly IC–induced IFN- production in vivo depends on 
TLR3 and IFN-IR but not on MyD88 or Cardif. Mice with the indicated 
genotype were injected i.v. with 100 µg poly IC. After 3–4 h, sera were 
analyzed for IFN- and IFN-. Circles indicate the results of individual 
mice, and their total number (n) is indicated in the graph. The bars repre-
sent the mean of all mice per genotype. At least three independent ex-
periments have been performed.2706 CD8+ cDCs are major producers of IFN- | Lauterbach et al.
To clarify which DC subset would be the source of IFN- 
production to poly IC in vivo, we used mice lacking the 
transcription factor IRF8 and as a consequence CD8+ and 
eCD8 cDCs (Schiavoni et al., 2002; Aliberti et al., 2003; 
To rule out lymphocytes as a source of the systemic IFN- 
production in vivo, we tested IL-15R–KO and RAG-KO 
mice, which lack NK cells and B cells and T cells, respec-
tively, but found that both strains were able to produce nor-
mal WT levels of IFN- (Fig. 3 B) and IFN- (Fig. S4 A).   
To identify the cellular source of the systemic IFN-, we tested 
FL-KO mice, which are known to have greatly reduced 
numbers of DCs (McKenna et al., 2000). In contrast to WT 
mice, poly IC–injected FL-KO mice were unable to produce 
IFN- (Fig. 3 C), whereas IFN- was produced (Fig. S4 B), 
suggesting a role for DCs in the production of IFN- to 
poly IC in vivo. Application of recombinant FL into FL-KO 
mice not only restored but even increased their IFN-– 
producing capacity above the WT level (unpublished data). 
Along those lines, FL-treated WT mice, which display ele-
vated DC numbers, skewed toward increased CD8+ cDCs 
and  eCD8  cDCs  (O’Keeffe  et  al.,  2002;  Bedoui  et  al., 
2009), had a greatly increased systemic IFN- response to 
poly IC challenge (unpublished data). The FL dependence 
suggests that IFN- production to poly IC in vivo is largely 
mediated by DCs.
Figure 2.  IFN- production to poly IC in vivo depends on IRF3 and 
IRF7. Mice with the indicated genotype were injected i.v. with 100 µg 
poly IC. After 3–4 h, sera were analyzed for IFN- and IFN-. Circles indi-
cate the result of individual mice, and their total number (n) is indicated 
in the graph. The bars represent the mean of all mice per genotype. Three 
independent experiments have been performed.
Figure 3.  IFN- production to poly IC in vivo depends on hemato-
poietic cells, FL, and IRF8. Mice with the indicated genotype were in-
jected i.v. with 100 µg poly IC, and after 3–4 h, sera were analyzed for 
IFN-. (A) BM reconstituted mice as indicated. (B) WT, IL-15R–KO, and 
RAG1-KO. (C) WT and FL-KO. (D) WT and IRF8-KO. Circles indicate the 
result of individual mice, and their total number (n) is indicated in the 
graph. The bars represent the mean of all mice per genotype. One (BM 
chimeras in A and IL-15R–KO in B), two (WT and RAG-KO in B and WT and 
IRF8-KO in D), and three (WT and FL-KO in C) independent experiments 
have been performed.JEM VOL. 207, November 22, 2010 
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IFN-, and its production was confined to enriched prepara-
tions of DCs (unpublished data). Therefore, we used a DC 
isolation protocol, which included density enrichment, de-
pletion of T cells, B cells, NK cells, and granulocytes, and 
multiparameter fluorescence-activated cell sorting. Those 
highly purified DC subsets were stimulated with a panel of 
TLR ligands in vitro and IFN-, and other cytokines and 
chemokines were determined in the supernatants. pDCs were 
the major source of IFN- in response to the A-type ODN 
CpG-2216 (Fig. S1), as previously suggested by messenger 
RNA analysis of human pDCs (Coccia et al., 2004). How-
ever, in response to poly IC stimulation, the CD8+ cDCs 
were the major producers of IFN-, with CD8 cDCs, either 
expressing CD4 (CD4+ cDCs) or not (DN cDCs), and pDCs 
being largely unable to participate in IFN- production (Fig. 5 A 
and Fig. S1 A). The IFN- production was selective for poly 
IC stimulation and for CD8+ cDCs even though many dif-
ferent TLR ligands induced robust activation in CD8+ and 
CD8 cDCs, as seen by the induction of the other cyto-
kines (Fig. 5 B). As described previously, some TLR ligands 
were selective for certain DC subsets, with CD8+ cDCs being 
unresponsive to the TLR7 stimulation via R848, but in contrast 
being the sole responder to the TLR11 ligand profilin (Fig. 5 B 
and Fig. S1 B; Edwards et al., 2003; Yarovinsky et al., 2005).
IFN- and IL-12p70 production by CD8+ cDCs depends  
on the type of stimulus and the cytokine conditions
CD8+ cDCs are well known for their exceptional capacity 
for IL-12p70 production. Because we found that the CD8+ 
cDCs were also able to produce large amounts of IFN-, we 
next  elucidated  the  conditions  that  would  govern  IFN- 
compared with IL-12p70 production. By using a panel of dif-
ferent TLR stimuli, we found that TLR ligands known for 
their high IL-12p70 induction such as CpG-ODN or profilin 
of toxoplasma (Hochrein et al., 2000; Yarovinsky et al., 2005) 
induced large amounts of IL-12p70 as expected, but surpris-
ingly the CD8+ cDCs did not produce any IFN- under 
these conditions (Fig. 6 A). In contrast, poly IC stimulation 
induced  IFN-  but  not  IL-12p70  production  by  CD8+ 
cDCs (Fig. 6 A). Combinations of poly IC together with 
Pam3Cys, LPS, CpG-ODN, or profilin, ligands for TLR2, 
TLR4, TLR9, or TLR11, respectively, synergistically increased 
IFN- production (Fig. 6 A). The data demonstrate a syner-
gistic increase of poly IC–induced IFN- with MyD88- 
dependent stimuli and confirm described synergistic effects 
on the production of IL-12p70 by CD8+ cDCs (Fig. 6 A; 
Napolitani et al., 2005).
Previously, we and others have shown that the cytokine 
milieu during stimulation is highly influential for IL-12p70 
production in murine and human DCs, with IL-4 being a major 
enhancer for bioactive IL-12 production (Hochrein et al., 
2000; Kalinski et al., 2000). Using poly IC or CpG-1668 or a 
combination of poly IC and CpG-1668 as stimuli, we ana-
lyzed the effect of the addition of either IFN- or IL-4 on 
the production of IFN- and IL-12p70. IFN- enhanced the 
production of IFN- to poly IC or the combination of poly 
Edelson et al., 2010). In contrast to WT mice, IRF8-KO mice 
were unable to produce IFN- to poly IC challenge in vivo, 
strongly suggesting that CD8+ and eCD8 cDCs were the 
source of IFN- (Fig. 3 D).
Poly IC injection in vivo induces IFN- production in spleen 
cells with the phenotype of CD8+ cDCs
Because gene deletions of the aforementioned mice may af-
fect several functions, we decided to confirm the conclusion 
obtained so far. For this, we injected poly IC i.v. into WT 
mice, dissected the spleen, and cultured the splenocytes in vitro. 
IFN- was detected in the supernatant of cultured total spleen 
cells (Fig. 4, A–C). Separation of the splenocytes with a density 
centrifugation, a step used to enrich DCs in the light density 
fraction, revealed that most IFN- was associated with these 
light density cells. (Fig. 4 A).
As an alternative approach to investigate the role of DCs 
in the IFN- production to poly IC in vivo, we used mice 
transgenic for the diphtheria toxin (DT) receptor (DTR) under 
the control of the CD11c promoter (CD11c-DTR-tg; Jung 
et al., 2002). CD11c is highly expressed in cDCs and to a minor 
extent in pDCs, some lymphocytes, and certain macrophages 
of the spleen (Jung et al., 2002; Probst et al., 2005). Our initial 
unpublished  experiments  confirmed  that  splenocytes  of   
DT-untreated CD11c-DTR-tg mice produced IFN- upon 
poly IC injection in vivo. Next, we treated WT and CD11c-
DTR-tg mice with DT to ablate DCs in vivo. After injection   
of poly IC in vivo, spleen cells of the DT-treated WT but not 
DT-treated CD11c-DTR-tg mice produced IFN- (Fig. 4 B), 
suggesting a role of CD11c+ cells, probably DCs, as the main 
source of IFN-.
The previous two separation experiments indicated that 
among splenocytes of poly IC–injected mice, light density 
DCs that highly expressed CD11c were the major source of 
IFN-. To rule out other cell types and get an insight into the 
subset of DCs involved, poly IC was injected in WT mice, and 
1.5–2 h later, total spleen cells were separated with a set of 
antibodies and magnetic beads into positive and negative frac-
tions. The IFN- production separated with cells negative for 
CD3 (T cells), CD45R (B cells and pDCs), CD11b (macro-
phages and CD8 cDCs), CD172a (macrophages, pDCs, and 
CD8 cDCs), and NK1.1 (NK cells) but positive for CD11c 
(DCs) and CD8 (CD8 cDCs and CTLs). Thus, upon poly 
IC injection in vivo, the IFN- production in splenocytes 
segregated with cells of light density and the phenotype   
CD3,  CD45R,  NK1.1,  CD11b,  CD172a,  CD11c+, 
and CD8+. This phenotype exactly describes CD8+ cDCs 
and excludes other cell types of the spleen such as lympho-
cytes or macrophages as major producers of IFN- to poly IC 
injection in vivo.
CD8+ cDCs are the major producers of IFN- in response 
to poly IC in vitro
Stimulation of fractionated spleen cells with different TLR li-
gands in vitro revealed that the major lymphocyte fractions 
consisting of T and B lymphocytes were unable to produce 2708 CD8+ cDCs are major producers of IFN- | Lauterbach et al.
thus regarded as eCD8 cDCs (Bedoui et al., 2009). These 
cells are expanded by repeated FL injections. To test whether 
ex vivo isolated eCD8 cDCs share other functional similari-
ties with CD8+ cDCs, we expanded DCs with FL in vivo 
and sorted CD8+ cDCs, eCD8 cDCs, and the remaining 
cDCs, which highly express CD11b and CD172a. Both, the 
CD8+ and eCD8 cDCs but not the CD11b/CD172a-
expressing cDCs produced large amounts of IFN- to poly 
IC and high IL-12p70 to CpG-1668 or profilin, indicating 
that eCD8 cDCs share the high IFN-– and IL-12p70–
producing capacity of CD8+ cDCs (Fig. 7 A).
IC and CpG-1668, whereas still no IFN- was induced to 
CpG-1668 only (Fig. 6 B). As described previously, IFN- 
had little effect on the IL-12p70 production, whereas IL-4 
increased  IL-12p70  but  not  IFN-  production  (Fig.  6  B;   
Hochrein et al., 2000).
In vivo and in vitro FL-induced equivalents of CD8+ cDCs 
produce IFN- to poly IC
Spleen cDCs contain a very small fraction of DCs, which do 
not express CD8 but otherwise resemble the CD8+ cDCs 
in phenotype and their cross-presentation ability and are 
Figure 4.  The IFN- production to poly IC injection in vivo separates with CD45R/CD11c+/CD8+ splenocytes. 1.5–2 h after i.v. injection 
of poly IC, spleens were harvested and processed. Cell-free supernatants were analyzed for IFN- after in vitro culture for 18 h. (A) 5 × 106 cells/ml  
of total spleen cells or cells separated by density centrifugation into light density cells or heavy density cells. (B) 25 × 106 cells/ml of total spleen cells 
of WT or CD11c-DTR-tg mice treated 2 d before with DT. (C) Total spleen cells before separation or after magnetic bead separation into the denoted 
populations. The initial cell number of splenocytes added onto the column was 20 × 106. Without further counting, each fraction was distributed into 
2 wells with 200 µl of medium/well. Bars represent the mean ± SD of two independent experiments (A and C) or one experiment (B) using two mice 
per experiment.JEM VOL. 207, November 22, 2010 
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generated  and  sorted  eCD8  cDCs 
from the FL cultures of WT, MyD88-
KO, Cardif-KO, TLR3-KO, and IFN-
IR–KO mice. The production of IFN- 
by FL-eCD8 cDCs upon stimulation 
with poly IC was dependent on TLR3 
and IFN-IR but was independent of 
MyD88 and Cardif (Fig. S3, A–D). 
Thus,  the  systemic  production  of 
IFN- in vivo and the production   
in vitro by directly stimulated eCD8 
cDCs were governed by the same set 
of receptors, especially TLR3, which 
is highly expressed and known to be 
used for poly IC detection by CD8+ 
cDCs  (Schulz  et  al.,  2005). These 
data strongly suggest that CD8+ and 
eCD8 cDCs are the source of poly 
IC–induced IFN- in vivo.
Production of IFN- and IL-12p70 
upon selective stimulation indicates 
the presence of CD8+ or eCD8 
cDCs in the liver
Based on the data accumulated thus 
far, we hypothesized that the produc-
tion of IFN- and IL-12p70 exclu-
sively  induced  by  certain  stimuli  in 
CD8+ and eCD8 cDCs might be used to identify the pres-
ence of these DCs in complex mixtures of cells. For the high-
est production of both factors in vitro, we used a combination 
of cytokines (IL-3 + GM-CSF + IL-4 + IFN-), which pro-
motes both IFN- and IL-12p70 production. As stimuli, we 
used poly IC or profilin or the combination of poly IC + 
profilin, which are stimuli highly selective for CD8+ and 
eCD8 cDCs (Fig. 5 and Fig. S1). First, we wanted to test the 
selectivity of these stimuli for CD8+ cDCs within splenic 
cDC subsets. Indeed, we confirmed the stimulus-dependent 
production of IFN- to poly IC, IL-12p70 to profilin, or the 
combined production of IFN- and IL-12p70 to the combi-
nation of poly IC + profilin exclusively by CD8+ cDCs 
(Fig. S2 A). Stimulations of nonparenchymal liver cells under 
these conditions revealed the same pattern of IFN- and   
IL-12p70 production (Fig. S2 B), indicating the presence of 
The culture of BM cells with FL in vitro induces the   
development of DC subsets, including eCD8 cDCs, with   
phenotypic, developmental, and functional similarities with 
CD8+ cDCs (Hildner et al., 2008; Naik et al., 2010). Com-
paring eCD8 cDCs and CD11b/CD172a-expressing cDCs 
revealed that similar to ex vivo isolated cDC subsets, the mu-
tually exclusive stimulus-dependent production of IFN- or 
IL-12p70 was mostly confined to the eCD8 subset (Fig. 7 B). 
Thus, eCD8 cDCs either ex vivo isolated or in vitro gener-
ated share with CD8+ cDCs the ability for high IFN- as 
well as IL-12p70 production.
In vivo, we had found that poly IC–induced IFN- was in-
dependent of the presence of the adaptor molecules MyD88 and 
Cardif but depended on TLR3 and IFN-IR (Fig. 1). Because the 
in vitro generated eCD8 cDCs showed such a similar pro-
duction of IFN- as their ex vivo isolated counterparts, we 
Figure 5.  Splenic CD8+ cDCs are the 
major producers of IFN- in response to 
poly IC in vitro. Highly purified 5 × 105 cells/
ml of splenic cDC subsets were stimulated in 
the presence of IL-3 and GM-CSF with the 
stimuli as indicated. (A and B) After 18 h, 
supernatants were analyzed for IFN- (A) or 
IL-6, TNF, CCL3, and CCL4 (B). Bars represent 
the mean ± SD of three (A) or two (B) inde-
pendent experiments using the pool of at 
least eight mice per experiment.2710 CD8+ cDCs are major producers of IFN- | Lauterbach et al.
CD8+ or eCD8 cDCs as previously 
shown  (Sumpter  et  al.,  2007).  Liver   
cells from FL-KO mice, known to 
have drastically reduced numbers of 
DCs, were largely unable to produce 
IFN- or IL-12p70 under these con-
ditions (Fig. S2 B).
CD8+ cDCs, eCD8 cDCs, and pDCs 
produce IFN- to HSV-1  
and parapoxvirus
To extend our analysis of IFN- pro-
duction in response to the dsRNA viral 
mimic poly IC to bona fide viruses, 
we stimulated ex vivo isolated splenic 
DC subsets from FL-expanded mice 
and DC subsets of in vitro generated 
FLDCs with HSV-1, parapoxvirus, and 
Sendai virus and analyzed the superna-
tants for IFN-. Among the spleen DC 
subsets, CD8+ cDCs, eCD8 cDCs, 
and pDCs produced large amounts 
of IFN- in response to HSV-1 and 
parapoxvirus (Fig. 8 A). The CD8 
cDCs  sorted  as  CD11b/CD172ahigh 
cDCs produced only very limited but, 
in contrast to the stimulation with poly 
IC,  detectable  amounts  (between  100 
and 400 pg/ml) of IFN- upon stimu-
lation with HSV-1 or parapoxvirus. 
Figure 6.  The production of IFN- or  
IL-12p70 by CD8 + cDCs depends on  
the stimuli and the cytokine conditions.  
5 × 105 cells/ml of sorted splenic CD8+ cDCs 
were stimulated, and supernatants were ana-
lyzed after 18 h for IFN- and IL-12p70.  
(A) Stimulation in the presence of IL-3 and 
GM-CSF with the stimuli as indicated.  
(B) Stimuli and cytokines as indicated. Bars 
represent the mean ± SD of two independent 
experiments using a pool of at least eight  
mice per experiment.
Figure 7.  In vivo and in vitro FL- 
generated CD8+ cDCs and eCD8  
cDCs are major producers of IFN- and  
IL-12p70. (A and B) 5 × 105 cells/ml of highly 
purified splenic DCs from FL-treated mice  
(A) or FLDCs (B) were stimulated in the pres-
ence of IL-3 + GM-CSF + IL-4 + IFN- with 
the stimuli as indicated. After 18 h, superna-
tants were analyzed for IFN- and IL-12p70. 
Bars represent the mean ± SD of two inde-
pendent experiments each using a pool of at 
least two mice per experiment.JEM VOL. 207, November 22, 2010 
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we performed experiments injecting HSV-1. In contrast to 
the results with poly IC, the majority of the HSV-1–induced 
IFN- was within the CD45R-positive fraction (Fig. 9). This 
suggested that probably pDCs, which beside B cells express 
CD45R, are the major producers. We separated the CD45R-
negative fraction into a CD8-positive and -negative fraction 
of cells. All remaining IFN- production within the CD45R-
negative  fraction  segregated  with  the  CD8-positive  cells 
(Fig. 9). These data suggest that the CD8+ cDCs, which are 
CD45R/CD8+, participate in the IFN- production upon 
HSV-1 inoculation in vivo.
Human BDCA3+ DCs are the major producers of IFN-s 
upon poly IC stimulation
We found that the IFN- production in response to poly IC 
in mice is a CD8+ cDC subset–specific feature, and there-
fore, we wanted to determine whether this function corre-
lated with any human DC subset. Given that human BDCA3+ 
DCs are attributed as functional correlates of CD8+ cDCs, 
we stimulated PBMCs, PBMCs depleted of cDCs, and highly 
enriched fractions of BDCA1+ and BDCA3+ cDCs and mea-
sured IFN-1 and IFN-2 in the supernatants. In PBMCs 
(Fig.  10)  and  fractions  of  DC-enriched  PBMCs  (not  de-
picted), we found that poly IC induced IFN-1 (IL-29) and 
IFN-2 (IL-28A). Separation of cDC subsets using the mark-
ers BDCA1 or BDCA3 revealed that the BDCA3+ cells were 
the major producers of IFN-1 as well as IFN-2 (Fig. 10). 
Thus, IFN- production upon poly IC stimulation is another 
functional attribute that the human BDCA3+ cDCs share with 
murine CD8+ and eCD8 cDCs.
DISCUSSION
In this study, we have shown that poly IC, an outstanding   
adjuvant,  induces  IFN-  production  by  human  BDCA3+ 
(CD141+) and mouse CD8+ cDCs, subsets which are also 
Only pDCs and none of the cDC subsets produced IFN- in 
response to Sendai virus (Fig. 8 A). FLDC subsets generated 
in vitro displayed a very similar pattern with IFN- produc-
tion to HSV-1 and parapoxvirus mostly associated with 
eCD8 cDCs and pDCs with a very limited contribution by 
CD11b/CD172ahigh cDCs (Fig. 8 B). Again, all IFN- to 
Sendai virus was selectively produced by pDCs but not from 
the cDC subsets (Fig. 8 B). Thus, like pDCs, CD8+ and 
eCD8 cDCs are able to respond in vitro to some viruses 
with the production of large amounts of IFN-.
HSV-1 injection in vivo indicates that among splenocytes, 
pDCs and CD8+ cDCs produce IFN-
Similar  to  our  approach  to  identify  the  IFN-  producers 
among spleen cells in response to poly IC injection (Fig. 4 C),   
Figure 8.  In vivo and in vitro FL-generated CD8+ cDCs, eCD8 
cDCs, and pDCs are major producers of IFN- to HSV-1 and 
parapoxvirus. (A and B) 5 × 105 cells/ml of highly purified splenic DCs 
from FL-treated mice (A) or FLDCs (B) were stimulated in the presence 
of IL-3 + GM-CSF + IL-4 + IFN- with the stimuli as indicated. After  
18 h, supernatants were analyzed for IFN-. Bars represent the mean ± SD 
of two independent experiments each using a pool of at least two mice 
per experiment.
Figure 9.  The IFN- production to HSV-1 injection in vivo  
separates with CD45R+ and CD45R/CD8+ splenocytes. Spleen cells 
1.5 h after in vivo injection with DISC–HSV-1 were separated with anti-
CD45R and magnetic beads into positive and negative fractions. The CD45R-
negative fraction was further separated into cells positive or negative for 
CD8. Separated cells were cultured in vitro for the next 18 h, and cell-
free supernatants were analyzed for IFN-. Bars represent the mean ± SD 
of two independent experiments using one mouse per experiment.2712 CD8+ cDCs are major producers of IFN- | Lauterbach et al.
and cellular bases for this IFN- were unknown. We and others 
have described that CD8+ cDCs but not the CD8 cDCs 
were producers of IFN- in response to poly IC stimulation 
in vitro (Hochrein et al., 2001; Longhi et al., 2009). Recently, 
it became clear that DCs are not responsible for the systemic 
production of IFN-. Poly IC–driven IFN- induction de-
pends on the RLH MDA5 and originates from cells of non-
hematopoietic origin (Gitlin et al., 2006; Longhi et al., 2009). 
These data were further corroborated in TLR3-KO and 
Batf3-KO mice, which lack the dsRNA recognition receptor 
predominantly used by CD8+ cDCs or CD8+ cDCs per se, 
respectively. Induction of poly IC–induced systemic IFN- 
was not impaired in these mice (Gitlin et al., 2006; Longhi et al., 
2009; McCartney et al., 2009; Edelson et al., 2010).
In this study, we have provided evidence that poly IC in-
duces early systemic IFN- production. To our knowledge, 
this is the first report of directly measured systemic IFN-  
in response to poly IC in vivo. Indirect evidence of systemic 
poly IC–induced IFN- was provided by Ank et al. (2008), 
who nicely demonstrated that antiviral protection induced by 
poly IC partially depended on the presence of the IFN- re-
ceptor (IL-28R).
In vitro, the induction of IFN- transcripts was reported 
by the first papers that described the discovery of the IFN-s 
(Kotenko et al., 2003; Sheppard et al., 2003). Many studies 
have since extended those findings in several cells types in vitro, 
including GM-CSF–derived murine and human monocyte-
derived DCs (GM-DCs), macrophages, and pDCs (for review 
see Ank and Paludan, 2009). One study demonstrated induc-
tion of IFN- upon stimulation with Sendai virus, HSV-2, 
poly IC, and B-type ODN (CpG-1826) in GM-DCs (Ank et al., 
2008) and another with LPS or CD40L (Wolk et al., 2008).   
In contrast, we could only find limited amounts of IFN-  
in ex vivo isolated or in vitro with FL-generated CD11b/
CD172ahigh cDCs induced by the DNA viruses HSV-1 and 
parapoxvirus but none to Sendai virus (Fig. 8), to poly IC, or 
the other TLR ligands (Figs. 5 and 7), even though the viruses 
induced some IFN- in those CD11bhigh cDCs (Hochrein et al., 
2004; Siegemund et al., 2009; Luber et al., 2010). We have 
also analyzed GM-DCs, but again we could only find limited 
amounts of IFN- to HSV and parapoxvirus but none to 
Sendai virus or poly IC or a panel of TLR ligands including 
B-type ODN (CpG-1668; unpublished data). However, com-
paring the protocols for the generation of GM-DCs, we real-
ized substantial differences in the duration of culture and thus 
the maturation state of these DCs. It will be interesting to 
elucidate the basis of the differences in the IFN- production 
capacity of non-CD8+ cDCs. It is important to note that our 
in vivo analyses and ex vivo isolated DC subset analyses and 
organ stimulations were performed using healthy pathogen-
free mice. Under these noninflammatory steady-state condi-
tions, all of our in vivo and in vitro data point to CD8+ and 
eCD8 cDCs as the sole and nonredundant producers of 
early IFN- upon poly IC exposure. It has been shown previ-
ously that these steady-state conditions have no substantial 
numbers of inflammatory DCs (e.g., monocyte-derived DCs 
specialized in IL-12p70 production and cross-presentation.   
In response to poly IC, IFN- was not coexpressed with 
IL-12p70 unless MyD88-dependent stimuli were also sensed 
by these cells. Because poly IC is shown in this study to di-
rectly target CD8+ cDCs for IFN- induction, it is tempt-
ing to speculate that this cytokine constitutes an important 
component of the poly IC–induced adjuvant response. Un-
derstanding the individual adjuvant components of poly IC 
may permit the design of vaccines with enhanced antiviral 
responses but minimal side effects. Moreover, poly IC is a 
mimic of viral dsRNA, and the IFN- responses to this adju-
vant are potentially mirrored in the response to numerous 
DNA and RNA viruses that produce dsRNA intermediates 
or potentially other pathogen-associated patterns. The recent 
studies linking IFN- to hepatitis C viral clearance highlight 
the potential importance of this cytokine in viral disease (Ge 
et al., 2009; Suppiah et al., 2009; Tanaka et al., 2009; Thomas 
et al., 2009). Moreover, the role of IFN- extends beyond viral 
disease. It is reported that TH1-inducing properties (Jordan et al., 
2007) could have potential use as an adjuvant in airway dis-
eases in which its production is possibly deficient (Contoli et al., 
2006). It has also been shown that IFN- induces apoptosis in 
epithelial cell tumors (Brand et al., 2005), raising the possibil-
ity that it may function as a tumor suppressor.
Poly IC is a well-known agent that induces systemic levels 
of IFN- in experimental animals. Until recently, the molecular 
Figure 10.  Human BDCA3+ cDCs are major producers of IFN- 
upon poly IC stimulation. PBMCs, PBMCs depleted of BDCA1 and 
BDCA3, or cells positively selected either for BDCA1 or BDCA3 were stim-
ulated in the presence of IL-3, GM-CSF, and IFN- with 100 µg/ml poly IC + 
10 µg/ml Pam3Cys + 10 µg/ml LPS (donor 1) or with 100 µg/ml poly IC  
for 18–24 h (donors 2 and 3). Supernatants were analyzed for IFN-1 and 
IFN-2. The experiments are shown for the individual donors, and data 
represent mean ± SD of duplicate samples.JEM VOL. 207, November 22, 2010 
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IFN-–producing DC subsets is somehow linked to the IFN- 
producing capacity grants further examination.
In this study, we describe that IRF3 and IRF7 play im-
portant roles in the poly IC–induced IFN- and IFN- pro-
duction in vivo (Fig. 2). A role for IRF3 has been previously 
described for the induction of IFN-I downstream of both 
PRRs involved, the RLHs as well as for TLR3 (Tamura et al., 
2008). Interestingly, in the absence of IRF3, no IFN- but 
some remaining IFN- was produced, whereas in the absence 
of IRF7, we found a remaining IFN- but completely abro-
gated IFN- production. An essential role for IRF7 has been 
demonstrated previously for MyD88-dependent IFN- pro-
duction by pDCs, and a participation of IRF7 in TRIF- 
dependent IFN-I production by DCs has been proposed (Honda 
et al., 2005; Tamura et al., 2008). Our in vivo findings of a 
prominent role for both IRF3 and IRF7 for the production 
of IFN- in response to poly IC are in line with previous 
promoter-based data (Osterlund et al., 2007). We have per-
formed some preliminary experiments with eCD8 cDCs 
sorted from FLDCs, which confirmed the complete depen-
dence on IRF3 for the production of IFN- in response to 
poly IC (unpublished data). For stimulations of eCD8 cDCs 
from IRF7-KO with poly IC, the role of IRF7 seemed to be 
less prominent, which makes it possible that the role of IRF7 
in vivo is indirect, for example via the complete absence of 
IFN- (Fig. 2), but this has to be confirmed with more de-
tailed experiments. We have shown that the IFN- production 
in IFN-IR–deficient mice is not only reduced upon poly IC in 
vivo (Fig. 1) but also by eCD8 cDCs stimulated with poly IC 
in vitro (Fig. S3 D), suggesting that the lack of IFN-IR on 
CD8+ cDCs is directly responsible for this effect. The expres-
sion of IFN-IR by DCs and especially by CD8+ cDCs was 
previously shown to be important for their function in antigen 
presentation (Longhi et al., 2009; Cucak et al., 2009), and a 
positive feedback mechanism by IFN-I on the production of 
IFN- has previously been described (Ank et al., 2008). Be-
cause the IFN- production to poly IC in vivo and in vitro was 
not fully abrogated in the absence of the IFN-IR, this leaves a 
window for the activity of poly IC–induced IFN- in the ab-
sence of the IFN-IR. Indeed, Ank et al. (2008) have shown 
that the protective effect of poly IC to HSV infection was par-
tially dependent on the IFN-R and functional in the absence 
of IFN-IR. However, IRF8 is highly expressed by CD8+ 
DCs (Luber et al., 2010), and both IRF3 and IRF7 play a role 
in IFN- production by CD8+ DC in response to poly IC. It 
is possible that the role of IFN-IR is not only limited to an 
IFN-I feedback signaling at the time of stimulation but that it 
might play a role in the expression and/or regulation of es-
sential IRFs such as IRF8, IRF3, or IRF7 in the DCs during 
their development. This is currently under investigation.
We found that upon poly IC injection in vivo, only splenic 
CD11c+/CD8+ cells but not other splenic cell populations 
such as lymphocytes or macrophages could produce IFN-. 
Highly purified splenic DCs stimulated in vitro confirmed 
that the CD8+ cDCs selectively produced IFN- to poly IC 
but not to any other sole TLR ligand, whereas pDCs produced 
or TIP DCs; for review see Shortman and Naik, 2007). This 
situation may change dramatically upon infection or inflam-
mation, circumstances which we have not analyzed. It is 
known that inflammatory cytokines such as IFN-Is, IFN-, 
GM-CSF, or TNF dramatically alter the cytokine production 
capacity of many immune and nonimmune cells, and some 
studies indicate that this might also be the case for the produc-
tion of IFN-s (Sirén et al., 2005; Ank et al., 2006; Megjugorac 
et al., 2010).
We found that systemic IFN- originated from hemato-
poietic cells and among those exclusively from CD8+ and 
eCD8 cDCs, and its production was fully dependent on 
TLR3 but independent of the adaptor molecules for other 
TLRs or RLHs, MyD88 or Cardif, respectively. In contrast, 
and confirming previous data (Gitlin et al., 2006; Longhi   
et al., 2009), we found that the production of systemic IFN- 
was independent of TLR3 but fully dependent on Cardif. 
CD8+ cDCs highly express and recognize poly IC via TLR3 
(Edwards et al., 2003; Schulz et al., 2005), whereas they hardly 
express the RLHs (Luber et al., 2010). It is interesting to see 
that the same danger signal (dsRNA) induces early and high   
systemic levels of two different IFN families. This danger   
signal is not only sensed by two different families of PRRs 
(TLRs and RLHs) but also by completely different cellular 
sources (CD8+ cDCs and nonhematopoietic cells).
Mice deficient in FL have drastically reduced but not fully 
absent numbers of DCs, including CD8+ cDCs. Based on 
the reduced numbers of DCs, we expected to detect residual 
IFN- production upon poly IC stimulation. However, the 
production of IFN- by FL-KO mice was nearly completely 
abolished in vivo (Fig. 3 C) and in liver cells in vitro (Fig. S2 B). 
Previously,  we  found  that  pDCs  isolated  from  FL-KO   
mice were inhibited in their production of IFN- upon 
TLR9 stimulation (unpublished data). This suggested that 
DCs from FL-deficient mice might also be functionally im-
paired or alternatively that these non-FL–dependent DCs are 
a subset of the normal steady-state DC populations and do 
not share the same functional attributes with FL-dependent 
DCs. In line with our observations, it was found recently that 
mice with a mutation in the receptor for FL (flt3) demon-
strated a severely reduced production of cytokines upon TLR 
stimulation of their DCs, including CD8+ cDCs (Eidenschenk 
et al., 2010).
Mice deficient for IRF8 have defects in the development 
of pDCs and CD8+ and eCD8 cDCs (Aliberti et al., 2003; 
Edelson et al., 2010). In line with the absence of CD8+ 
cDCs, we found that IRF8-KO mice were unable to produce 
systemic IFN- to poly IC. Like FL, IRF8 seems to play an 
additional functional role, as demonstrated by the impaired 
IFN- production by pDCs (Tailor et al., 2007), which was 
not further examined in our study. However, it is interesting 
to note that both DC subsets able to produce large amounts 
of IFN-, pDCs and CD8+ cDCs, not only depend on IRF8 
for their development but also express high levels of IRF8 when 
isolated as end-stage cells from spleen (Luber et al., 2010). 
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Bunkyo-ku, Tokyo, Japan; Honda et al., 2005), IRF8-KO from I. Horak 
(Leibniz Institut für Molekulare Pharmakologie, Berlin, Germany; Holtschke 
et al., 1996), and C57BL/6 WT mice purchased from Harlan Winkelmann 
GmbH, Elevage Janvier, or the Walter and Eliza Hall Institute of Medical Re-
search bred C57BL/6. Protocols for animal experimentation were approved 
by the government of upper Bavaria (Regierung von Oberbayern) or by the 
Walter and Eliza Hall Institute of Medical Research or University of Mel-
bourne Animal Ethics Committees.
Cells and flow cytometric sorting. DC subsets were isolated from pooled 
mouse spleens as described previously (Vremec et al., 2007). In brief, spleens 
were chopped, digested with collagenase (Worthington Biochemical) and DNase 
(Roche) at room temperature, and treated with EDTA. Low-density cells 
were enriched by density centrifugation; non-DC lineage cells were coated 
with mAbs (anti-CD3 [KT3-1.1], anti–Thy-1 [T24/31.7], anti–Gr-1 [1A8], 
anti-CD19 [ID3], anti-erythrocytes [TER119], and anti–NK cells [DX5]) 
and depleted using anti–rat Ig magnetic beads (QIAGEN). Dead cells were 
excluded by propidium iodide staining. cDC populations were sorted based 
on the expression of CD11c, CD45RA, CD4, CD8, and CD172a, and 
pDCs were purified based on CD11c, CD45RA, and CD172a (all from BD) 
expression. Cell sorting was performed on a FACS Aria instrument (BD).
To generate FL-induced DCs in vivo, mice were treated i.p. with nine 
doses of FL (10 µg/day), and spleen DCs were enriched on day 10 as de-
scribed in the previous paragraph. pDCs were sorted as CD11cint, CD45RAhigh, 
CD11bneg,  and  CD172aint  cells;  CD8+  cDCs  were  sorted  as  CD11cpos, 
CD45RAneg, CD11bneg/low, CD172aneg, CD24high, and CD8apos cells; eCD8 
cDCs  were  sorted  as  CD11cpos,  CD45RAneg,  CD11bneg/low,  CD172aneg,   
CD24high,  and  CD8neg  cells;  CD11b/CD172ahigh  cDCs  were  sorted  as   
CD11cpos, CD45RAneg, CD11bhigh, CD172ahigh, CD24neg/low, and CD8neg cells.
FL BM culture–derived DCs (FLDCs) were prepared as described previ-
ously (Hochrein et al., 2004). pDCs and eCD8 and CD11b/CD172high 
cDC subsets were sorted based on the expression of CD11c, CD45R, CD11b, 
CD24, and CD172a (all from BD).
In vitro stimulation and cytokine detection. Cells were stimulated in vitro 
with single TLR agonists or combinations thereof containing 10 µg/ml   
Pam3Cys (InvivoGen), 100 µg/ml poly IC (Axxora), 10 µg/ml LPS (Esche-
richia coli; Sigma-Aldrich or Axxora), 10 µg/ml R848 (Axxora), 1 µM CpG-1668 
or CpG-2216 (TIB-Molbiol), and 1 µg/ml profilin of toxoplasma (Axxora). 
The recombinant cytokines mouse IL-3, mouse IL-4, rat IFN- (PeproTech), 
and mouse GM-CSF (Tebu-Bio; 10 ng/ml each) were added as indicated.   
The addition of IL-3 and GM-CSF was based on our previous observations 
that GM-CSF promoted the production of IL-12p70 (Hochrein et al., 2000) and 
that the combination of IL-3 and GM-CSF increased virus-induced IFN- 
production in pDCs and cDCs (Hochrein et al., 2004). DISC–HSV-1 (HSV-1 
disabled infectious single cycle)  is a replication-deficient form of HSV-1, 
which lacks the gene for glycoprotein H and has to be propagated on trans-
genic feeder cells. In noncomplementing cells, it can perform only a single   
cycle of infection (McLean et al., 1994). The virus has been shown to be 
equally potent as a WT HSV-1 to induce IFN- in pDCs and cDCs in vitro 
(Hochrein et al., 2004). Inactivated parapoxvirus ovis used in veterinary sci-
ence (Pfizer Animal Health) was described to induce IFN-/ in pDCs and 
cDCs (Siegemund et al., 2009). Sendai virus strain Cantell (Charles River) was 
described to induce IFN- in pDCs and CD11bhigh but not CD8+ cDCs 
(Luber  et  al.,  2010).  IFN-  in  supernatants  was  analyzed  by  ELISA,  and   
IL-12p70, IL-6, TNF, CCL3, and CCL4 were determined by FlowCytomix 
bead assay (Bender MedSystems) according to the manufacturer’s protocol. 
Note that IFN- was analyzed by an IFN-3 (IL-28B) ELISA (R&D Systems), 
but we found that this ELISA is largely cross-reactive to IFN-2 (IL-28A) and 
thus were not able to differentiate between these two mouse IFN-s.
Liver cell preparation. To obtain liver cell suspensions for stimulation cul-
tures, livers were harvested from mice, chopped into small pieces, and incubated 
with 1 ml collagenase D (1 mg/ml; Roche) at 37°C for 30 min. Single-cell 
suspensions were then prepared by mechanically disrupting the organs through 
IFN- to CpG-2216. Beside ex vivo isolated CD8+ cDCs, 
equivalents of those cells (eCD8 cDCs) expanded by FL in vivo 
or in vitro shared the high IFN-– and IL-12p70–producing 
capacity, a feature previously not described for ex vivo iso-
lated FL-expanded eCD8 cDCs. eCD8 cDCs have been 
identified based on their dependence on the transcription 
factors IRF8 or Batf3 to be present in several lymphoid and 
nonlymphoid  organs  (Hildner  et  al.,  2008;  Edelson  et  al., 
2010). Our selective stimulations of liver cells indicated that 
eCD8 or CD8+ cDCs were present, and cells with this 
phenotype  have  been  previously  identified  in  the  liver 
(Sumpter et al., 2007). Thus, IFN- production seems to be a 
function of lymphoid and nonlymphoid organ eCD8 or 
CD8+ cDCs.
Research on human cDC subsets has, until recently, relied 
on phenotypical analysis, which indicated that certain surface 
markers  such  as  Clec9a  or  Necl2  selectively  expressed  by 
mouse CD8+ cDCs were associated with a human blood DC 
subset that could be identified by expression of CD141 (BDCA3). 
We had previously shown that the IL-12p70 production of 
thymic human cDC subsets was preferentially localized to   
the CD11b subset (Vandenabeele et al., 2001). Recently, the 
evidence for human BDCA3+ cDCs as the mouse eCD8 
equivalents was substantiated in parallel by four groups who 
demonstrated that among human cDCs, BDCA3+ cDCs, like 
their mouse counterparts, highly express TLR3, produce IL-
12p70, and possess superior cross-presenting activity (Bachem 
et al., 2010; Crozat et al., 2010; Jongbloed et al., 2010; Poulin 
et al., 2010; Villadangos and Shortman, 2010). We have now 
shown that the newly discovered function of mouse CD8+ 
and eCD8 as the major producers of IFN- in response to 
poly IC is conserved throughout evolution to the human 
eCD8 (BDCA3+) cDCs.
We do not yet know all of the consequences of the dedi-
cation of a single cell type to produce IFN- to dsRNA, nor 
do we know the full consequences of IFN- in the network 
of defense and immunoregulation. However, the strong func-
tional conservation of similar cell types between mice and 
man is an indication of importance, and it strengthens the 
likelihood that certain aspects of IFN- biology, including its 
regulation and novel therapeutic strategies based on experi-
mental work performed in mice, will translate into humans.
MATERIALS AND METHODS
Mice. Mice were bred and maintained either in the animal facilities at   
Bavarian Nordic GmbH, the Max Planck Institute of Biochemistry, the Max 
Planck Institute of Immunobiology, the Amrep Animal facility, the Walter and 
Eliza Hall Institute of Medical Research, the University of Melbourne, or at 
the  University  of  Zurich  according  to  institutional  guidelines.  Breeding 
stocks were originally obtained from MyD88-KO and TRIF-KO mice from 
S. Akira (Osaka University, Suita, Osaka, Japan; Adachi et al., 1998), Cardif-
KO mice from J. Tschopp (University of Lausanne, Epalinges, Switzerland; 
Meylan et al., 2005), FL-KO mice (McKenna et al., 2000), transgenic mice 
that express the primate DTR under the control of the CD11c promoter 
from S. Jung (The Weizmann Institute of Science, Rehovot, Israel; Jung et al., 
2002), TLR3-KO (Alexopoulou et al., 2001), IL-15R–KO (Lodolce et al., 
1998) and RAG1-KO (Mombaerts et al., 1992) mice from The Jackson Lab-
oratory, IRF3-KO and IRF7-KO mice from T. Taniguchi (University of Tokyo, JEM VOL. 207, November 22, 2010 
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